Legal & General Group
IMGN

Legal & General Group’s Immunogen Inc IMGN Stock Holding History

Legal & General Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-235,326
Closed -$6.98M – 3397
2023
Q4 		$6.98M Buy
235,326
+20,751
+10% +$413K ﹤0.01% 1339
2023
Q3 		$3.41M Buy
214,575
+2,026
+1% +$33.7K ﹤0.01% 1649
2023
Q2 		$4.01M Buy
212,549
+120,064
+130% +$1.42M ﹤0.01% 1588
2023
Q1 		$355K Buy
92,485
+6,294
+7% +$26.8K ﹤0.01% 2413
2022
Q4 		$428K Buy
86,191
+1,236
+1% +$6.7K ﹤0.01% 2375
2022
Q3 		$406K Buy
84,955
+6,463
+8% +$34.1K ﹤0.01% 2402
2022
Q2 		$353K Sell
78,492
-1,388
-2% -$6.03K ﹤0.01% 2437
2022
Q1 		$380K Buy
79,880
+1,837
+2% +$10.2K ﹤0.01% 2468
2021
Q4 		$579K Buy
78,043
+2,433
+3% +$15.1K ﹤0.01% 2368
2021
Q3 		$428K Buy
75,610
+38,481
+104% +$222K ﹤0.01% 2461
2021
Q2 		$245K Buy
37,129
+52
+0.1% +$363 ﹤0.01% 2480
2021
Q1 		$300K Buy
37,077
+3,884
+12% +$31.7K ﹤0.01% 2379
2020
Q4 		$214K Sell
33,193
-3,638
-10% -$21.2K ﹤0.01% 2405
2020
Q3 		$133K Sell
36,831
-7,688
-17% -$31K ﹤0.01% 2424
2020
Q2 		$205K Buy
44,519
+503
+1% +$2.14K ﹤0.01% 2360
2020
Q1 		$150K Buy
44,016
+4,596
+12% +$20.1K ﹤0.01% 2323
2019
Q4 		$201K Buy
39,420
+1,803
+5% +$6.12K ﹤0.01% 2398
2019
Q3 		$91K Buy
37,617
+11,045
+42% +$29.3K ﹤0.01% 2556
2019
Q2 		$58K Hold
26,572
– – ﹤0.01% 2715
2019
Q1 		$72K Hold
26,572
– – ﹤0.01% 2604
2018
Q4 		$128K Buy
26,572
+3,621
+16% +$22K ﹤0.01% 2407
2018
Q3 		$218K Buy
22,951
+2,392
+12% +$23K ﹤0.01% 2312
2018
Q2 		$200K Buy
20,559
+1,375
+7% +$14.5K ﹤0.01% 2297
2018
Q1 		$202K Sell
19,184
-5,275
-22% -$52.1K ﹤0.01% 2292
2017
Q4 		$159K Buy
24,459
+2,933
+14% +$18.1K ﹤0.01% 2408
2017
Q3 		$163K Sell
21,526
-4,159
-16% -$27.6K ﹤0.01% 2415
2017
Q2 		$184K Hold
25,685
– – ﹤0.01% 2329
2017
Q1 		$99K Sell
25,685
-2,380
-8% -$6.95K ﹤0.01% 2549
2016
Q4 		$51K Buy
28,065
+13,207
+89% +$26.5K ﹤0.01% 2887
2016
Q3 		$40K Sell
14,858
-6,866
-32% -$20K ﹤0.01% 2625
2016
Q2 		$67K Hold
21,724
– – ﹤0.01% 2323
2016
Q1 		$188K Buy
21,724
+2,538
+13% +$21.5K ﹤0.01% 1762
2015
Q4 		$258K Hold
19,186
– – ﹤0.01% 1642
2015
Q3 		$187K Buy
19,186
+6,866
+56% +$100K ﹤0.01% 1740
2015
Q2 		$173K Hold
12,320
– – ﹤0.01% 1807
2015
Q1 		$113K Hold
12,320
– – ﹤0.01% 1962
2014
Q4 		$77K Hold
12,320
– – ﹤0.01% 2169
2014
Q3 		$135K Buy
+12,320
New +$139K ﹤0.01% 1711

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legal & General Group's IMGN Position: Q1 2024 in Review

Legal & General Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 235,326 shares — an estimated $6.98M sold.

Legal & General Group first reported a position in IMGN in Q3 2014 and held it in 38 quarters. The position peaked at $6.98M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Legal & General Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Legal & General Group sold 235,326 Immunogen Inc shares in Q1 2024, an estimated $6.98M.
  • Legal & General Group first reported a position in Immunogen Inc in Q3 2014 and held it in 38 quarters.
  • Legal & General Group's Immunogen Inc position peaked at $6.98M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Legal & General Group's 13F filing for Q1 2024, filed 14 May 2024.